Neoadjuvant Chemotherapy With or Without GnRH Agonist for Premenopausal Triple-negative Early Breast Cancer Patients

Conditions: Triple Negative Breast Cancer; Premenopausal Breast Cancer Interventions: Drug: Goserelin Acetate 3.6mg 、Goserelin Acetate 10.8mg、Leuprolide Acetate 3.75mg、Leuprorelin Acetate 22.5mg、Triptorelin pamoate 11.25mg、Triptorelin pamoate 22.5mg Sponsors: National Taiwan University Hospital; Ministry of Health and Welfare; Debiopharm International SA Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials